The multiplex operator said strong performance from blockbuster titles, including Dhurandhar – The Revenge, Border 2 and Project Hail Mary, supported the earnings recovery.

With Tuesday’s decline, the stock is down 6% in two sessions.

Revenue from operations for Q4FY26 rose 26% year-on-year to Rs 1,547 crore, up from Rs 1,230 crore reported in the corresponding quarter of the previous financial year. On a sequential basis, profit after tax rose 95% to Rs 187 crore from Rs 96 crore in Q3FY26, even as revenue declined 16% quarter-on-quarter to Rs 1,850 crore in the October–December period.

During the quarter, the company recorded 31 million admissions, reflecting a 2% year-on-year increase. Average ticket price (ATP) stood at Rs 315, up 22% from a year ago, while spend per head (SPH) rose 32% year-on-year to Rs 165.

Live Events

PVR Inox share price: Should you buy, sell, or hold?

Nuvama Institutional Equities has maintained its “Buy” rating on PVR INOX, with a revised target price of Rs 1,620 from Rs 1,605 earlier, implying 58% upside potential. The brokerage expects FY27 to remain strong, driven by a healthy Bollywood and regional film pipeline along with a steady slate from Hollywood. It has retained its earnings estimates and noted that at the current market price, the stock trades at 13x and 11x FY27E and FY28E earnings, respectively. Nuvama noted that the company’s net debt has declined 90% since the 2023 merger, marking its lowest level since the consolidation.
Elara Capital has maintained its “Buy” rating on PVR INOX with a target price of Rs 1,300, implying an upside potential of 27%. The brokerage said occupancy levels could sustain in the 25-27% range, supported by a stronger near-term content pipeline that includes titles such as Drishyam 3, Star Wars: The Mandalorian and Grogu, Ramayana Part 1, King, Avengers: Doomsday, Dune: Part 3, Toy Story 5, Toxic and Jailer 2. Elara Capital, however, expects growth in ATP and SPH to moderate after the normalisation seen in FY26. It added that the company’s FOCO and asset-light expansion strategy is likely to support lower capital expenditure intensity and improve free cash flow generation going ahead.
Motilal Oswal Financial Services has maintained a “Neutral” rating on PVR INOX with a target price of Rs 1,125, indicating a potential upside of 10%. The brokerage said a recovery in Hollywood box office collections, along with a strong content pipeline across multiple languages, is expected to support the company, particularly given its higher exposure to premium screening formats.

Also read: Groww shares sink 7% as Peak XV, Sequoia, others launch Rs 5,637-crore stake sale amid IPO lock-in expiry

Motilal Oswal also noted that PVR INOX has made significant progress in controlling operating costs, optimising capital expenditure and reducing debt on its balance sheet. However, it cautioned that the business remains highly sensitive to occupancy levels. While management remains optimistic about the CY26 content slate, the brokerage warned that even a 200-300 basis point decline in occupancy could materially hurt screen-level economics and EBITDA performance, creating downside risks to its current estimates.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Operator

Ladies and gentlemen, greetings, and welcome to the Quantum Computing, Inc. First Quarter 2026 Shareholder Update Call. [Operator Instructions] It is now my pleasure to introduce your host, John Nesbett with IMS Investor Relations.

John Nesbett

Thank you, and I want to welcome everyone to the Quantum Computing, Inc. First Quarter 2026 Shareholder Update Call. Before we begin, please note that today’s remarks may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding expected results, operational plans, strategy and market opportunities. These statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act and Section 21E of the Exchange Act and are based on current assumptions and expectations.

Forward-looking statements are neither promises nor guarantees and involve risks and uncertainties that could cause actual results to differ materially. Important factors are discussed in our annual report on Form 10-K for the year ended December 31, 2025, and in subsequent SEC filings, including the quarterly report on Form 10-Q for the quarter ended March 31, 2026. We undertake no obligation to update these statements, except as required by law.

On the call today, we have Dr. Yuping Huang, Chief Executive Officer and Chairman; and Chris Roberts, Chief Financial Officer. The team will provide

The Quadria Capital-backed company has held preliminary discussions with investment banks about a potential listing and may appoint advisers in the coming weeks, the people said, asking not to be identified because the information is private.

The proposed IPO could include a mix of fresh share issuance and secondary sales by existing investors, the people said. Deliberations are ongoing, and details such as size and timing could change.

A representative for Nobel Hygiene said the company regularly evaluates strategic and capital market opportunities and engages with external advisers from time to time as part of that process.

Indian firms have raised about $3.1 billion through IPOs so far this year, compared with roughly $22 billion in all of 2025, according to data compiled by Bloomberg.

Live Events

Quadria Capital, one of Asia’s largest healthcare-focused private equity firms, announced in 2021 that it had acquired a significant minority stake in Nobel Hygiene.
Founded in 2000 by Kamal Johari, the company manufactures hygiene products tailored to Indian consumers, according to its website.